🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT02259959
The primary objective of this study is to assess the safety of 52 weeks onc...
Status
Completed
Location
1237.22.81015 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01536262
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.9.00152 Boehringer Ingelheim Investigational Site
Start Date
2008-07
Trial ID
NCT00720499
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of 12 week...
Status
Completed
Location
1237.26.10620 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT02006732
Treatments Being Tested
The aim of this trial is to evaluate the safety and efficacy of 2.5 and 5 µ...
Status
Completed
Location
205.464.81020 Boehringer Ingelheim Investigational Site
Start Date
2011-04
Trial ID
NCT01340209
Treatments Being Tested
The overall objective is to assess the effect of once daily tiotropium + ol...
Status
Completed
Location
1237.19.10039 Boehringer Ingelheim Investigational Site
Start Date
2015-01-13
Trial ID
NCT02296138
Treatments Being Tested
The overall objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
1237.5.01038 Boehringer Ingelheim Investigational Site
Start Date
2011-09
Trial ID
NCT01431274
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.4.0118 Boehringer Ingelheim Investigational Site
Start Date
2008-06
Trial ID
NCT00696020
Treatments Being Tested
The overall objective of this study is to assess efficacy and safety of 12 ...
Status
Completed
Location
1222.52.02090 Boehringer Ingelheim Investigational Site
Start Date
2012-09
Trial ID
NCT01696058
Treatments Being Tested
The primary objective of this study is to assess pharmacokinetics of tiotro...
Status
Completed
Location
1237.24.24001 Boehringer Ingelheim Investigational Site
Start Date
2012-10
Trial ID
NCT01703845
Treatments Being Tested